Unpacking open innovation: Absorptive capacity, exploratory and exploitative openness, and the growth of entrepreneurial biopharmaceutical firms

Tools

Xia, Tianjiao ORCID: https://orcid.org/0000-0001-7686-4460 and Roper, Stephen (2016) Unpacking open innovation: Absorptive capacity, exploratory and exploitative openness, and the growth of entrepreneurial biopharmaceutical firms. Journal of Small Business Management, 54 (3). pp. 931-952. ISSN 0047-2778

Full text not available from this repository.

Abstract

In this article, we explore the relationship between two key aspects of open innovation in small firms—absorptive capacity (ACAP) and external relationships—and their effects on growth in the U.S. and European biopharmaceutical sectors. Results from an international sample of 349 biopharmaceutical firms surveyed in the United States, United Kingdom, France, and Germany suggest that realized ACAP plays an important role in determining firms’ growth. In terms of the interaction between firms’ ACAP and external relationships, we find that engagement with exploratory relationships depends strongly on the continuity of R&D, while participation in exploitative relationships is more conditional on firms’ realized ACAP.

Item Type:	Article
Uncontrolled Keywords:	business, management and accounting(all),strategy and management,management of technology and innovation ,/dk/atira/pure/subjectarea/asjc/1400
Related URLs:	http://www.scopus.com/inward/record.url?...
Depositing User:	LivePure Connector
Date Deposited:	19 May 2020 00:21
Last Modified:	19 Jul 2023 10:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/75218
DOI:	10.1111/jsbm.12220

Actions (login required)

View Item